Absci Stock (NASDAQ: ABSI) stock price, news, charts, stock research, profile.
Open | $5.230 |
Close | $5.080 |
Volume / Avg. | 536.637K / 1.493M |
Day Range | 5.055 - 5.440 |
52 Wk Range | 1.111 - 6.720 |
Market Cap | $583.510M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 0 |
Short Interest | 13.76% |
Days to Cover | 8.26 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Absci (NASDAQ: ABSI) through any online brokerage.
Other companies in Absci’s space includes: Cabaletta Bio (NASDAQ:CABA), Humacyte (NASDAQ:HUMA), Valneva (NASDAQ:VALN), Celcuity (NASDAQ:CELC) and Korro Bio (NASDAQ:KRRO).
The latest price target for Absci (NASDAQ: ABSI) was reported by Truist Securities on Tuesday, March 26, 2024. The analyst firm set a price target for 9.00 expecting ABSI to rise to within 12 months (a possible 74.42% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Absci (NASDAQ: ABSI) is $5.16 last updated May 3, 2024 at 7:39 PM EDT.
There are no upcoming dividends for Absci.
Absci’s Q1 earnings are confirmed for Tuesday, May 14, 2024.
There is no upcoming split for Absci.
Absci is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.